Cargando…
Tuberculosis vaccine research in China
It is now privately acknowledged that there may be little if any perceptible impact of the national Bacille Calmette–Guerin (BCG) vaccination program on disease prevalence, despite the extensive coverage of the newborn infant population and likely benefit in the early years of life. A better prevent...
Autor principal: | Lowrie, Douglas B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3636423/ https://www.ncbi.nlm.nih.gov/pubmed/26038419 http://dx.doi.org/10.1038/emi.2012.3 |
Ejemplares similares
-
Research Advances for Virus-vectored Tuberculosis Vaccines and Latest Findings on Tuberculosis Vaccine Development
por: Hu, Zhidong, et al.
Publicado: (2022) -
Mycobacterium tuberculosis from chronic murine infections that grows in liquid but not on solid medium
por: Dhillon, Jasvir, et al.
Publicado: (2004) -
The Profile of T Cell Responses in Bacille Calmette–Guérin-Primed Mice Boosted by a Novel Sendai Virus Vectored Anti-Tuberculosis Vaccine
por: Hu, Zhidong, et al.
Publicado: (2018) -
Where are the RNA vaccines for TB?
por: Fan, Xiao-Yong, et al.
Publicado: (2021) -
Research and development of new tuberculosis vaccines: a review
por: Schrager, Lewis K., et al.
Publicado: (2019)